Teva Pharmaceutical Industries Limited’s TEVA share price has dipped by 13.89%, which has investors questioning if this is ...

In a clinical guideline issued by the American College of Gastroenterology and published in the January issue of the American ...

Optinose (NASDAQ: OPTN) has announced preliminary unaudited net product revenue of $22.4 million for the fourth quarter of ...

by ICS-subtype consisting of a ‘fluticasone-group’ (fluticasone propionate or fluticasone furoate) and an ‘MBBC-group’ (mometasone furoate, beclomethasone, budesonide or ciclesonide). The outcome was ...

Optinose, Inc. (OPTN), a pharmaceutical company focused on ear, nose and throat or ENT and allergy, announced Wednesday preliminary ...

Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced preliminary ...

announced today a preliminary unaudited net product revenue of $22.4 million for XHANCE (fluticasone propionate) for the fourth quarter ending December 31, 2024. The company, currently trading ...

Nasal Steroid Sprays for the Treatment of Allergies In February 2015, Flonase (fluticasone) nasal spray became available OTC. Flonase is the second intranasal corticosteroid nasal (INS) spray to be ...

Fluticasone Furoate {(FF), 110 micrograms once daily}, and Fluticasone Propionate {(FP), 200 micrograms once daily} in AR. Nasal symptoms were evaluated using a Visual Analog Scale of 1 to 10, Nasal ...

Please provide your email address to receive an email when new articles are posted on . The ACG developed 19 recommendations related to the diagnosis and management of eosinophilic esophagitis ...